文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

作者信息

Visseren Frank L J, Mach François, Smulders Yvo M, Carballo David, Koskinas Konstantinos C, Bäck Maria, Benetos Athanase, Biffi Alessandro, Boavida José-Manuel, Capodanno Davide, Cosyns Bernard, Crawford Carolyn, Davos Constantinos H, Desormais Ileana, Di Angelantonio Emanuele, Franco Oscar H, Halvorsen Sigrun, Hobbs F D Richard, Hollander Monika, Jankowska Ewa A, Michal Matthias, Sacco Simona, Sattar Naveed, Tokgozoglu Lale, Tonstad Serena, Tsioufis Konstantinos P, van Dis Ineke, van Gelder Isabelle C, Wanner Christoph, Williams Bryan

机构信息

European Geriatric Medicine Society (EuGMS).

European Federation of Sports Medicine Association (EFSMA).

出版信息

Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.

DOI:10.1093/eurheartj/ehab484
PMID:34458905
Abstract
摘要

相似文献

[1]
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

Eur Heart J. 2021-9-7

[2]
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

Eur J Prev Cardiol. 2022-2-19

[3]
Current European guidelines for management of cardiovascular disease: Is medical treatment in nearly half a population realistic?

Eur J Prev Cardiol. 2017-11-2

[4]
CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.

JACC Cardiovasc Imaging. 2016-9-21

[5]
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions.

Eur J Prev Cardiol. 2024-10-10

[6]
[Guideline on the assessment and management of cardiovascular risk in China].

Zhonghua Yu Fang Yi Xue Za Zhi. 2019-1-6

[7]
Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.

Eur J Prev Cardiol. 2023-11-30

[8]
[Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention].

Hipertens Riesgo Vasc. 2022

[9]
Editorial: The 2021 European Society of Cardiology (ESC) Guidelines on the Real-World Prevention of Atherosclerotic Cardiovascular Disease (ASCVD).

Med Sci Monit. 2021-10-25

[10]
Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention.

Clin Investig Arterioscler. 2022

引用本文的文献

[1]
Association of cardiovascular risks and carotid stiffening at ultrafast ultrasound imaging in young populations.

Eur Radiol. 2025-9-8

[2]
Prescription of lipid-lowering drugs and their association with hospitalization for ST-elevation myocardial infarction (STEMI) in Germany in 2010-2022.

Clin Res Cardiol. 2025-9-8

[3]
European survey on metabolic and cardiovascular risk in Cushing syndrome.

J Endocrinol Invest. 2025-9-6

[4]
Proposal of Platelet Anti-aggregation in Transplant Renal Artery Stenosis.

Cureus. 2025-8-2

[5]
From guidelines to practice: LDL-C achievement in very high cardiovascular risk patients - analysis of the EDHIPO MARCA registry.

Lipids Health Dis. 2025-9-2

[6]
A randomized controlled trial of the short-term effect of rosuvastatin on the corrected QT interval.

Sci Rep. 2025-9-1

[7]
Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide.

Am J Cardiovasc Drugs. 2025-9-1

[8]
Pathological post-systolic shortening as a prognostic marker for major cardiovascular events in patients with type 2 diabetes.

Echo Res Pract. 2025-9-1

[9]
SGLT2 inhibitors and GLP-1 receptor agonists: impact on mortality in diabetic patients with cardiovascular disease.

Cardiovasc Diabetol. 2025-8-31

[10]
Psychosocial moderators of the effect of lifestyle interventions in primary prevention of cardiovascular disease: a scoping review.

BMC Public Health. 2025-8-30

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索